WANBURY
Back to Balance Sheet
|
WANBURY Last 5 Year Total Non-Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Non-Current Liabilities | ₹96 Cr | ₹11 Cr | ₹11 Cr | ₹84 Cr | ₹108 Cr |
What is the latest Total Non-Current Liabilities ratio of WANBURY ?
Year | Total Non-Current Liabilities |
---|---|
Mar2024 | ₹96 Cr |
Mar2023 | ₹11 Cr |
Mar2022 | ₹11 Cr |
Mar2021 | ₹84 Cr |
Mar2020 | ₹108 Cr |
How is Total Non-Current Liabilities of WANBURY Trending?
Years | Total Non-Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹96 Cr | 787.48 | |
Mar2023 | ₹11 Cr | 2.34 | |
Mar2022 | ₹11 Cr | -87.49 | |
Mar2021 | ₹84 Cr | -21.63 | |
Mar2020 | ₹108 Cr | - |
Compare Total Non-Current Liabilities of peers of WANBURY
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
WANBURY | ₹920.5 Cr | -7.3% | 11.3% | 16% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,466.0 Cr | -3% | -6.8% | -11.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹162,423.0 Cr | -0.5% | -8.4% | 25.1% | Stock Analytics | |
CIPLA | ₹128,405.0 Cr | -0.2% | 1% | -1.2% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹120,448.0 Cr | -3.4% | -5.6% | 6.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,408.0 Cr | -1.1% | -2.9% | -9.5% | Stock Analytics |
WANBURY Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
WANBURY | -7.3% |
11.3% |
16% |
SENSEX | -2.7% |
-1.3% |
-2.3% |
You may also like the below Video Courses